Bionomy Health review

Bionomy publishes category-specific prices and names its founder and pharmacy partners. Those disclosures are useful leads, not independent credential verification. Its no-membership/pay-per-prescription marketing coexists with a shop subscription selector, and the TRT page gives different lab amounts. Confirm the payment schedule and required testing before comparing an all-in cost.

Bionomy Health presents men’s telehealth care through Bionomy Health, Inc. It names Pranav K. Sharma as founding physician and attributes fulfillment to Strive and Absolute Pharmacy. Current terms identify Telegra-affiliated practitioners as the consultation and prescribing network; that is more specific than assuming every intake is personally reviewed by the founder. Terms limit service to adults in the 48 contiguous states, with a higher age threshold for some hormone therapies.

The service advertises a free, no-card intake and clinician review with chat follow-up. Terms disclose Telegra-affiliated practitioners and allow patients to request the assigned clinician’s name and license details. Sermorelin material describes IGF-1 monitoring, while TRT discusses bloodwork and titration. Confirm which tests are required and what they cost. Founder credentials and pharmacy certification descriptions remain seller claims, not independently checked professional status.

Sermorelin is advertised at $169/month. TRT cypionate is $149/month; enclomiphene is $99 at 12.5 mg or $109 at 25 mg. The payment page instead lists enclomiphene at $89/$99, conflicting with the $99/$109 shop and therapy prices. These are distinct products, not a single interchangeable hormone price. The TRT page lists a $75 testosterone panel and $199 wider panel, but its FAQ quotes an $89 initial panel. The payment page also quotes $89 initial/$79 follow-up labs, while the shop lists $75/$199 panels. It says no auto-renewal but describes approved 30-, 60- or 90-day supplies and subsequent fill charges at shipment; the shop displays one- and three-month subscription choices. Confirm supply, actual debit, refill authorization and required labs; do not assume no recurring commitment. The return policy permits a 50% refund of the most recent fill when a practitioner recommends discontinuation within 30 days of approval; it is not a blanket satisfaction guarantee. Labs are nonrefundable after requisition. Cancel before the next fill ships to avoid its charge; dispensed/shipped medication is not returnable.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Its footer names Strive and Absolute and claims certification and licensure; these are attributed disclosures, not independently verified credentials. Compounded drugs are not FDA-reviewed like approved products. On the evidence, sermorelin's effect on the growth-hormone axis is a real, well-described mechanism, but the long-term human outcome data behind it stays thin and no controlled trial shows it delivers the body-composition or recovery results it is marketed for. The NAD⁺ on the same longevity menu is compounded and injected, a route with no controlled human outcome trials at all; oral NR and NMN are the forms with human data, and they raise blood NAD⁺ rather than demonstrate a clinical benefit. If you take up the testosterone line as well, that therapy requires ongoing bloodwork and suppresses fertility. Individual results vary.